https://www.selleckchem.com/pr....oducts/Temsirolimus.
PHNs showed lower capacity for evaluating initiatives, tools and support for staff, and staff training. We critique the importance of weightings and scope of some capacity domains in the ORACLe tool. Despite this, with some minor modifications, we conclude the ORACLe tool can identify capacity strengths and limitations in meso-level PHC organizations. Well-targeted capacity development enables PHC organizations' strategies to be better informed by evidence, for optimal impact on PHC and population health outcomes. We critique the i